Medications

MSF challenges Pfizer's India vaccine patent application

Doctors Without Borders has challenged Pfizer's application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organizations.

Health

Using price to avoid vaccine shortages

No one worries about vaccine supply—until there's a shortage. New research from Duke University's Fuqua School of Business studied the market tensions that can keep manufacturers out of the business and the price points ...

Pediatrics

ACIP approves 2016 adult immunization schedule

(HealthDay)—The Advisory Committee on Immunization Practices (ACIP) has approved the recommended adult immunization schedule for 2016. The recommendations are published as a clinical guideline in the Feb. 2 issue of the ...

Pediatrics

No increase in febrile seizures with 2010-2011 TIV or PCV13

(HealthDay)—For the 2010-2011 influenza season, there was no increase in the risk of febrile seizures (FS) with the trivalent inactivated influenza vaccine (TIV) or the 13-valent pneumococcal conjugate vaccine (PCV13), ...

Pediatrics

PCV13 recommended for 6- to 18-year-olds at high risk

(HealthDay)—Pneumococcal conjugate vaccine 13 (PCV13) should be administered to certain children aged 6 through 18 years who are at high risk of invasive pneumococcal disease (IPD), according to a policy statement published ...

page 2 from 4